Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Oral retinoids like isotretinoin and acitretin can cause significant hair loss.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

The compound 4c showed strong potential as an anticancer agent.

Most HIV-positive patients had skin problems, and conditions like oral thrush and boils were linked to weaker immune systems.

Warts in HIV-positive men can have serious abnormal cell growth, needing careful analysis and treatment to prevent cancer.

Dilated pupils can be an early sign of HIV/AIDS.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

The issue discussed China's research contributions, systematic review improvements, and featured various medical studies and trials.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Ritlecitinib works well and is safe for treating alopecia areata.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

Combining two treatments for hair loss works better than using just one.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Indinavir therapy can cause reversible skin, hair, and nail darkening.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.